UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O O- O0 O1 O2 O3 OA OB OC OD OE OF OG OH OI OJ OK OL OM ON OO OP OR OS OT OU OV OW OX OY OZ
ON# ONA ONC OND ONE ONF ONH ONI ONL ONO ONR ONS ONT ONY
selected terms: 99 page 1 of 1

1. O'nyong-nyong virus
[ ] (UMLS (CSP) C0318742) =Virus
51. oncology, radiation
[A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer. ( MSH )] (UMLS (NCI) C0243005) =Biomedical Occupation or Discipline ;
2. On active military duty
(UMLS (HL7) C1546526) =Idea or Concept =Employment Status;
52. oncolysis
[The breakdown, or lysis, of a tumor. This can occur by mechanical means, chemicals, or infectious agents such as viruses. Oncolytic viruses do not lyse most normal cells. ( NCI )] (UMLS (NCI) C0333516) =Neoplastic Process
3. On discharge
(UMLS (HL7) C1548175) =Temporal Concept =Invocation event;
53. Oncolytic Virus
[Manipulated or engineered viruses having oncolytic properties to selectively replicate in and kill targeted cancer cells, leaving normal cells unharmed. ( NCI )] (UMLS (NCI) C0029020) =Virus ;
4. On foot
(UMLS (HL7) C1561537) =Intellectual Product =Mode of Arrival Code;
54. Oncomelania
[ ] (UMLS (CSP) C0324005) =Invertebrate
5. On hold as requested
(UMLS (HL7) C1548236) =Intellectual Product =Order control codes;
55. Onconase/TAM
(UMLS (NCI) C0338369) =Therapeutic or Preventive Procedure
6. On IV
(UMLS (HL7) C0677510) =Intellectual Product ;
=Precaution Code;
56. Oncophage
(UMLS (NCI) C0935952) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
7. On receipt of order
(UMLS (HL7) C1548176) =Temporal Concept =Invocation event;
57. oncoprotein
[proteins coded by oncogenes which potentially induce neoplastic transformation. ( CSP )] (UMLS (CSP) C0029005) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=gene product;
8. Onandaga
(UMLS (HL7) C1555644) Onondaga;
=Language =NorthernIroquoian;
58. oncornavirus
[An informal grouping of rna-containing viruses that are capable of inducing tumors. ( NCI )] (UMLS (CSP) C0079936) =Virus
9. Once a week
[One time per week. ( NCI )] (UMLS (NCI) C0558293) =Temporal Concept
59. OncoScint CR/OV
(UMLS (NCI) C0740254) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
10. Onchocerca
[A genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum. ( MSH )] (UMLS (CSP) C0028999) =Invertebrate
60. Oncostatin M
[Oncostatin M, a glycoprotein with an approximate molecular weight of 28,000, was originally isolated from a conditioned medium of human leukemia cells that had been induced to differentiate into macrophage-like cells by treatment with phorbol 12-myristate 13-acetate. OSM has the ability to inhibit the growth of human A375 melanoma cells but not normal human fibroblasts; hence, its name. It is a member of the IL-6 family of cytokines that is primarily known for its effects on cell growth. ( NCI )] (UMLS (NCI) C0069535) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
11. onchocerciasis
[infection with nematodes of the genus Onchocerca; characteristics include the presence of firm subcutaneous nodules filled with adult worms, pruritus, and ocular lesions. ( CSP )] (UMLS (CSP) C0029001) =Disease or Syndrome =filariasis;
=Ocular Onchocerciasis
61. Oncostatin M Gene
[This gene is involved in cytokine and growth regulation. ( NCI )] (UMLS (NCI) C1335093) OSM;
OSM Gene;
=Gene or Genome
12. Onclast
(UMLS (NCI) C1510843) =Organophosphorus Compound; Pharmacologic Substance
62. Oncostatin M Receptor
[Cell surface receptors with specificity for ONCOSTATIN M. Two subtypes of receptors have been identified and are defined by their subunit composition. ( MSH )] (UMLS (NCI) C0083861) =Amino Acid, Peptide, or Protein; Receptor
13. Oncocarbide
(UMLS (NCI) C0729129) =Organic Chemical; Pharmacologic Substance
63. Oncostatin M Receptor
[Encoded by human OSMR Gene, 111-kDa 979-aa Oncostatin-M Specific Receptor Beta Subunit is a subunit, with gp130 (a common subunit of IL6 family receptors), for a heterodimeric OSM receptor complex. OSMR contains characteristic motifs of the hematopoietin receptor family. OSM may bind to the gp130 subunit. (NCI) ( NCI )] (UMLS (NCI) C1173441) Oncostatin-M Specific Receptor Beta Subunit;
OSMR;
OSMRB;
=Amino Acid, Peptide, or Protein; Receptor ;
14. Oncocyte
[A glandular cell with acidophilic cytoplasm that contains tightly packed mitochondria. Oxyphil cells are found in the thyroid gland (Hurthle cells) and parathyroid gland. ( NCI )] (UMLS (NCI) C0949666) Oxyphil Cell;
Oxyphilic Cell;
=Cell
64. Oncostatin M Receptor Gene
[This gene is involved in cellular proliferation and receptor signaling. ( NCI )] (UMLS (NCI) C1335092) OSMR;
OSMR Gene;
=Gene or Genome
15. Oncocytic Neoplasm
[A usually benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm. Representative examples include oncocytic neoplasms of the thyroid gland, and kidney. (NCI05) ( NCI )] (UMLS (NCI) C1378050) Oncocytic Tumor;
Oncocytoma =Neoplastic Process
65. Oncotiotepa
(UMLS (NCI) C1305297) =Organophosphorus Compound; Pharmacologic Substance; Hazardous or Poisonous Substance
16. Oncocytoma of Salivary Gland
[A rare benign epithelial neoplasm composed of oncocytes, which are large cells with a large amount of granular eosinophilic cytoplasm containing numerous tightly-packed mitochondria. Approximately 85% to 90% occur in the parotid gland; most of the remainder occur in the submandibular gland. The peak incidence is in the seventh through ninth decades of life. In almost all cases, swelling is the only complaint of the patient. — 2003 ( NCI )] (UMLS (NCI) C1335906) Oncocytoma of the Salivary Gland;
Oxyphilic Adenoma of Salivary Gland;
Oxyphilic Adenoma of the Salivary Gland;
Salivary Gland Oncocytoma;
Salivary Gland Oxyphilic Adenoma =Neoplastic Process
66. OncoVax-PR
(UMLS (NCI) C0919275) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
17. oncofetal antigen
[ ] (UMLS (CSP) C0069494) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
67. Oncovin
(UMLS (NCI) C0591904) =Organic Chemical; Pharmacologic Substance ;
18. Oncogene CSF1R
[Human colony stimulating factor 1 receptor (CSF1R) gene, located at 5q33.2-q33.3, encodes macrophage colony stimulating factor I receptor protein. Mutations in this gene have been detected in both chronic myelomonocytic leukemia and type M4 acute myeloblastic leukemia. One out of fifty hematologically normal individuals exhibit a CSFR1 variant allele (Y969C) that may cause a predisposition to myeloid malignancy. ( NCI )] (UMLS (NCI) C0919447) Oncogene FMS =Gene or Genome ;
68. ONDANSETRON
[competitive serotonin type 3 receptor antagonist used in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs; also has anxiolytic and neuroleptic properties. ( CSP )] (UMLS (NCI) C0061851) =Organic Chemical; Pharmacologic Substance ;
=[GA700] ANTIEMETICS;
Carbazoles;
imidazole;
tranquilizer;
serotonin inhibitor;
=ONDANSETRON HYDROCHLORIDE;
ONDANSETRON 8 MG
19. Oncogene EGF
[Human Oncogene EGF is a mutated variant of EGF Gene, which encodes Epidermal Growth Factor, a 53-aa peptide hormone with profound effects on cell differentiation and potent mitogenic effects on a variety of ectodermal and mesodermal cells. The EGF precursor is believed to exist as a membrane-bound molecule that is proteolytically cleaved to generate the hormone. Oncogene EGF disrupts normal cell function. ( NCI )] (UMLS (NCI) C0919420) URG;
=Gene or Genome ;
69. ONE EXTRAOC MUS RECESS
[ ] (UMLS (ICD9CM) C0197972) =Therapeutic or Preventive Procedure
20. Oncogene Protein E2, Human Papilloma Virus Type 16
(UMLS (NCI) C0069501) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
70. One eye: moderate vision impairment; other eye: near-normal vision
[ ] (UMLS (ICD9CM) C0392585) =Disease or Syndrome
21. Oncogene Protein E4, Human Papilloma Virus Type 1
(UMLS (NCI) C0069502) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
71. One eye: moderate vision impairment; other eye: normal vision
[ ] (UMLS (ICD9CM) C0392586) =Disease or Syndrome
22. Oncogene Protein E4, Papillomavirus Type 11
(UMLS (NCI) C0133935) =Amino Acid, Peptide, or Protein; Biologically Active Substance
72. One eye: moderate vision impairment; other eye: vision not specified
[ ] (UMLS (ICD9CM) C0392584) =Disease or Syndrome
23. Oncogene Protein E4, Papillomavirus Type 6
(UMLS (NCI) C0133934) =Amino Acid, Peptide, or Protein; Biologically Active Substance
73. One eye: near-total vision impairment; other eye: vision not specified
[ ] (UMLS (ICD9CM) C0392575) =Disease or Syndrome
24. Oncogene Protein E6, Human Papilloma Virus Type 18
(UMLS (NCI) C0133937) =Amino Acid, Peptide, or Protein; Biologically Active Substance
74. One eye: profound vision impairment; other eye: near-normal vision
[ ] (UMLS (ICD9CM) C0392579) =Disease or Syndrome
25. Oncogene Protein E7 Human Papillomavirus Type 8
(UMLS (NCI) C0083856) =Amino Acid, Peptide, or Protein; Biologically Active Substance
75. One eye: profound vision impairment; other eye: normal vision
[ ] (UMLS (ICD9CM) C0392580) =Disease or Syndrome
26. Oncogene Protein, E2 Human Papillomavirus Type 18
(UMLS (NCI) C0133945) =Amino Acid, Peptide, or Protein; Biologically Active Substance
76. One eye: severe vision impairment; other eye: near-normal vision
[ ] (UMLS (ICD9CM) C0392582) =Disease or Syndrome
27. Oncogene Protein, E7 Human Papillomavirus Type 6
(UMLS (NCI) C0069527) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
77. One eye: severe vision impairment; other eye: normal vision
[ ] (UMLS (ICD9CM) C0392583) =Disease or Syndrome
28. Oncogene RAS
[Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Critically involved in cell activation and replication in many cell types, and disruption of its regulation can lead to uncontrolled growth. ( NCI )] (UMLS (NCI) C0034678) =Gene or Genome
78. One eye: severe vision impairment; other eye: vision not specified
[ ] (UMLS (ICD9CM) C0392581) =Disease or Syndrome
29. Oncogene SIS
[Human Oncogene SIS is a mutated variant of PDGFB Gene (PDGF/VEGF Family), which encodes 2 alternative isoforms of 241-aa 27-kDa (precursor) Platelet-Derived Growth Factor-Beta Chain, a potent mitogenic factor for mesenchymal cells characterized by a motif of eight cysteines and released by platelets upon wounding to stimulate adjacent cell growth; PDGF activates a RAS/PIK3/AKT1/IKK/NFKB1 pathway. PDGFB can exist as a disulfide-linked homodimer or heterodimer with Platelet-Derived Growth Factor Alpha. AA, BB, and AB, dimers bind to PDGF receptor and elicit a variety of cellular responses. A and B homodimers are implicated in transformation. PDGFB mutations are associated with meningioma. Reciprocal t(17;22)(q22;q13) translocations with COL1A1 result in unregulated growth factor expression and are associated with DFSP. Oncogene SIS disrupts normal cell function. ( NCI )] (UMLS (NCI) C0037207) =Gene or Genome ;
79. One eye: total vision impairment; other eye: near-normal vision
[ ] (UMLS (ICD9CM) C0392573) =Disease or Syndrome
30. Oncogene SKI
[This gene is involved in transcriptional regulation and is involved in cellular signal transduction. ( NCI )] (UMLS (NCI) C0812379) SKI;
V-SKI Sarcoma Viral Oncogene Homolog (Avian) Gene =Gene or Genome ;
80. One eye: total vision impairment; other eye: normal vision
[ ] (UMLS (ICD9CM) C0392574) =Disease or Syndrome
31. Oncogene SPI1
[This gene plays a role in transcriptional activation, cellular development and hematopoiesis. ( NCI )] (UMLS (NCI) C0919490) SPI1;
SPI1 Gene;
Spleen Focus Forming Virus (SFFV) Proviral Integration Oncogene SPI1 Gene;
Spleen Focus Forming Virus Proviral Integration Oncogene SPI1;
=Gene or Genome ;
81. One eye: total vision impairment; other eye: not specified
[ ] (UMLS (ICD9CM) C0521710) =Disease or Syndrome ;
32. Oncogene SRC
[Retrovirus-associated DNA sequences (src) originally isolated from the Rous sarcoma virus (RSV). The proto-oncogene src (c-src) codes for a protein that is a member of the tyrosine kinase family and was the first proto-oncogene identified in the human genome. The human c-src gene is located at 20q12-13 on the long arm of chromosome 20. ( NCI )] (UMLS (NCI) C0080298) =Gene or Genome ;
82. one time only.
(UMLS (HL7) C1548613) =Temporal Concept =Repeat;
33. Oncogene YES-1
[The gene product of oncogene YES-1 is associated with tyrosine kinase activity and its amino acid sequence shows high similarity with that of SRC. Multiple copies of YES-related genes occur in the human genome. Oncogene YES-1 is located at 18p11.31-p11.21. ( NCI )] (UMLS (NCI) C0812227) YES1;
YES1 Gene =Gene or Genome
83. Oneida
(UMLS (HL7) C0574553) =Language =NorthernIroquoian;
34. Oncogene, Transcription Factor
[Transcription factors that are encoded by oncogenes, a type of gene that contributes to the development of the malignant phenotype of a cell. Transcription factors interact with specific DNA sequences or DNA-binding proteins to initiate, stimulate, inhibit or terminate transcription. ( NCI )] (UMLS (NCI) C0812315) Oncogenes, Transcription Factors;
=Gene or Genome ;
84. Oneida Nation of New York
(UMLS (HL7) C1554397) =Population Group =NativeEntityContiguous;
35. Oncogenes, G-Proteins
[Mutated forms of G-protein genes which encode a diverse group of regulatory proteins that act as molecular switches. Under normal cellular conditions, the activity of these proteins is tightly controlled. Activation of G-protein proto-oncogenes via mutation results in G-protein oncogenes. These aberrant genes express protein products that disrupt normal cell function. ( NCI )] (UMLS (NCI) C0812217) =Gene or Genome
85. Oneida Tribe of Wisconsin
(UMLS (HL7) C1554398) =Population Group =NativeEntityContiguous;
36. Oncogenes, Growth Factor
[Mutated forms of growth factor genes which encode a diverse group of extracellular regulatory growth factor signaling molecules. These protein products play roles in the division, growth, proliferation, survival and differentiation of cells. Under normal cellular conditions, the activity of these proteins is tightly controlled. Activation of growth factor proto-oncogenes via mutation results in growth factor oncogenes. These aberrant genes express protein products that disrupt normal cell function. ( NCI )] (UMLS (NCI) C0812218) =Gene or Genome
86. Onion-Skinning Appearance
(UMLS (NCI) C1335112) =Finding ;
37. Oncogenes, Nuclear Protein
[Oncogenes that encode nuclear proteins. ( NCI )] (UMLS (NCI) C0812219) =Gene or Genome
87. online computer
[Systems where the input data enter the computer directly from the point of origin (usually a terminal or workstation) and/or in which output data are transmitted directly to that terminal point of origin. (Sippl, Computer Dictionary, 4th ed) ( MSH )] (UMLS (CSP) C0029038) =Manufactured Object; Intellectual Product =computer hardware;
38. Oncogenes, Protein-Kinase
[Human Protein-Kinase Oncogenes are mutated variants of Kinase Family Genes, which encode diverse Protein Kinases. Protein kinase enzymes catalyze the conversion of a protein to a phosphoprotein by covalently transferring the terminal, gamma phosphate group from ATP to a variety of substrates that typically play key regulatory roles in diverse cellular functions. Protein-Kinase oncogenes disrupt normal cell function. ( NCI )] (UMLS (NCI) C0812220) =Gene or Genome
88. Only
[Not accompanied by another or others; exclusive of anyone or anything else. ( NCI )] (UMLS (NCI) C0205171) =Quantitative Concept
39. Oncogenes, Tyrosine-Kinase
[Activated forms of tyrosine kinase family proto-oncogenes that contribute to the development of cancer. These proto-oncogenes encode tyrosine kinase proteins, which are enzymes that play a major role in mitogenic signaling by catalyzing the phosphorylation of tyrosine residues in proteins. Tyrosine kinase oncogenes exhibit aberrant gene expression, resulting in elevated levels of their protein products which disrupts mitotic checkpoints. ( NCI )] (UMLS (NCI) C0812221) =Gene or Genome
89. Only activity therapy and/or occupational therapy services provided
(UMLS (HL7) C1547479) =Intellectual Product =OCE Edit Code;
40. Oncogenesis
[The causation or production of tumors. ( NCI )] (UMLS (NCI) C1326912) tumorigenesis;
=Neoplastic Process
90. only child
[Child who has no siblings. ( MSH )] (UMLS (CSP) C0029039) =Family Group ;
41. Oncogenic Osteomalacia
(UMLS (NCI) C1274103) =Disease or Syndrome
91. Only edits present are for line item denial or rejection
(UMLS (HL7) C1547447) =Intellectual Product =Overall Claim Disposition Code;
42. oncogenic virus
[viruses that produce tumors; see RTs for specific organisms. ( CSP )] (UMLS (CSP) C0029017) =Virus ;
=virus characteristic;
=leukemia virus;
mammary tumor virus;
92. Only incidental services reported
(UMLS (HL7) C1547470) =Intellectual Product =OCE Edit Code;
43. oncogenic viruslike particle
[ ] (UMLS (CSP) C0599015) =Biologically Active Substance ;
93. Only the MSA segment is returned
(UMLS (HL7) C1548278) =Idea or Concept =Response flag;
44. Oncologic Nursing
[nursing care provided cancer patients; includes aspects of family functioning through education of both patient and family. ( CSP )] (UMLS (NCI) C0029019) =Biomedical Occupation or Discipline ;
=nursing care;
94. Onondaga Nation of New York
(UMLS (HL7) C1554399) =Population Group =NativeEntityContiguous;
45. oncologist
[(on-KOL-o-jist) A doctor who specializes in treating cancer. Some oncologists specialize in a particular type of cancer treatment. For example, a radiation oncologist specializes in treating cancer with radiation. ( NCI )] (UMLS (NCI) C0259990) =Professional or Occupational Group ;
95. Onset
[The start, beginning, or early stages. ( NCI )] (UMLS (NCI) C0332162) =Qualitative Concept
46. Oncology
[An entity, facility, or distinct part of a facility providing diagnostic, treatment and prescriptive services related to cancerous conditions. Services include chemotherapy infusions and monitoring of implanted chemotherapeutic agents. ( HL7V3.0 )] (UMLS (HL7) C1552534) =Manufactured Object; Health Care Related Organization =Clinic/Center;
96. ontogeny
[ ] (UMLS (CSP) C1621967) =Organism Function ;
47. Oncology
[Provision of treatment and/or diagnosis related to tumors and/or cancer. ( HL7V3.0 )] (UMLS (HL7) C1555459) =Idea or Concept =ActMedicalServiceCode;
◊ (UMLS (HL7) C1555997) Professional or Occupational Group Registered Nurse;
97. Onychia and paronychia of finger
[ ] (UMLS (ICD9CM) C0157692) =Disease or Syndrome
48. Oncology Nurse
[A nurse who specializes in treating and caring for people who have cancer. ( NCI )] (UMLS (NCI) C0557529) =Professional or Occupational Group
98. Onychia and paronychia of toe
[ ] (UMLS (ICD9CM) C0157694) =Disease or Syndrome
49. Oncology, Pediatrics
(UMLS (HL7) C1552243) =Professional or Occupational Group =Clinical Nurse Specialist;
99. ONYCHOPLASTY
[ ] (UMLS (ICD9CM) C0191796) =Therapeutic or Preventive Procedure
50. Oncology, Radiation
(UMLS (HL7) C1552438) =Manufactured Object; Health Care Related Organization =Clinic/Center;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM